Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098601 · ClinicalTrials.gov registry record · NA
Inpatient Link to Addiction Recovery
A NA study of Substance Use Disorders, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT04098601: Completed NA study of Substance Use Disorders, sponsored by Prisma Health-Upstate.
NCT04098601 is a NA study of Substance Use Disorders that has completed, run by Prisma Health-Upstate. The registered enrollment target is 103 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04098601, a NA study of Substance Use Disorders, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this proposal is to link inpatients to a certified peer support specialist through FAVOR-Greenville and determine the effectiveness of recovery coaching on patient outcomes.This study will evaluate the impact of initiating peer recovery coaching during SUD patients' hospitalization on engagement in recovery services, addiction severity, and quality of life compared to the current standard of care.
Primary Outcome
Active involvement in recovery care services, including but not limited to Alcoholics Anonymous Narcotics Anonymous, individual counseling, methadone/suboxone program, etc. This information is obtained from self-report surveys administered by medical students in both conditions at both baseline and each follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Recovery Coach Intervention
Study Locations (1)
South Carolina
- Greenville Memorial Hospital - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
What the finished NCT04098601 record still lists
NCT04098601 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Recovery Coach Intervention is the first listed.
NCT04098601 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT04098601 about?
NCT04098601 is a clinical study titled "Inpatient Link to Addiction Recovery". The objective of this proposal is to link inpatients to a certified peer support specialist through FAVOR-Greenville and determine the effectiveness of recovery coaching on patient outcomes.This study will evaluate the impact of initiating peer recovery coaching during SUD patients' hospitalization ...
What is the current status of trial NCT04098601?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2018-04-19. Estimated completion is 2019-12-30.
What conditions does trial NCT04098601 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT04098601?
The interventions under investigation include: Recovery Coach Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04098601?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04098601 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04098601's enrollment target sits among peer trials
103 52nd of 93 higher than 42 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI